Used as a key intermediate in pharmaceutical synthesis, particularly in the preparation of kinase inhibitors and other biologically active compounds. Its boronic acid functional group enables Suzuki-Miyaura cross-coupling reactions, allowing for the formation of carbon-carbon bonds in drug development. Commonly employed in the synthesis of anti-inflammatory, anticancer, and antidiabetic agents due to its stability and reactivity profile. Also utilized in the design of novel heterocyclic compounds where the pyrazole ring acts as a bioisostere for amide or ester functionalities.